Cite
MLA Citation
Geert D'Haens et al.. “Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.” Lancet, vol. 399, no. 10340, 2022, pp. 2015–2030. http://access.bl.uk/ark:/81055/vdc_100155168665.0x000056